Crohn’s disease and COVID-19: points of contact-Reference-Cited by-同舟云学术

Crohn’s disease and COVID-19: points of contact

Published:2023-01-23 Issue:11 Volume: Page:242-246
ISSN:1682-8658
Container-title:Experimental and Clinical Gastroenterology
language:
Short-container-title:jour

Author:

Markova A. A.¹^ORCID,Kashkina E. I.¹^ORCID,Aparkina A. V.¹^ORCID,Artyuhina L. V.¹^ORCID,Krasnikova V. I.¹^ORCID

Affiliation:

1. Saratov State Medical University named after V. I. Razumovsky

Abstract

The presented clinical case demonstrates the appearance of vivid clinical manifestations of Crohn’s disease after a COVID-19 infection. It was not possible to diagnose the disease in the early stages due to the lack of typical symptoms and the necessary examination. A new coronavirus infection acted as a trigger factor for the progression of Crohn’s disease. The diagnosis was confirmed during instrumental and laboratory studies, adequate therapy was prescribed, which led to a rapid relief of the attack of the disease.

Publisher

LLC Global Media Technology

Subject

Gastroenterology,Hepatology

Reference8 articles.

1. Ivashkin V. T., Shelygin Yu. A., Halif I. L. et al. Clinical recommendations of the Russian Gastroenterological Association and the Association of Coloproctologists of Russia on the diagnosis and treatment of Crohn’s disease. Coloproctology. 2017; (2): 7-29. (In Russ.) doi: 10.33878/2073-7556-2017-0-2-7-29.@@ Ivashkin V. T., Shelygin Yu. A., Khalif I. L. i dr. Klinicheskie rekomendatsii Rossiiskoi Gastroenterologicheskoi Assotsiatsii i Assotsiatsii Koloproktologov Rossii po diagnostike i lecheniyu bolezni Krona. Koloproktologiya. 2017; (2): 7-29. doi: 10.33878/2073-7556-2017-0-2-7-29.

2. Grinevich V. B., Kravchuk Yu.A., Ped V. I. et al. Management of patients with digestive diseases during the COVID-19 pandemic: Clinical Practice Guidelines by the Gastroenterological Scientific Society of Russia. Experimental and Clinical Gastroenterology. 2020; 179 (7):4-51. (In Russ.) doi: 10.31146/1682-8658-ecg-179-7-4-51.@@ Grinevich V. B., Kravchuk Yu. A., Ped' V. I. i dr. Vedenie patsientov s zabolevaniyami organov pishchevareniya v period pandemii COVID-19. Klinicheskie rekomendatsii Nauchnogo obshchestva gastroenterologov Rossii. Eksperimental'naya i klinicheskaya gastroenterologiya. 2020;179(7): 4-51. doi: 10.31146/1682-8658-ecg-179-7-4-51.

3. Hunt R. H., East J. E., Lanas A. et al. COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist. Dig Dis. 2020; Oct 9: 1-21. doi: 10.1159/000512152.

4. Hoffmann M., Kleine-Weber H., Schroeder S. et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020; Apr;181(2): 271-280.e8. doi: 10.1016/j.cell.2020.02.052 Medline.

5. Siddiqi H.K., Mehra M. R. COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal. J Heart Lung Transplant. 2020; May; 39(5):405-7. doi: 10.1016/j.healun.2020.03.012.